Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05442866 · ClinicalTrials.gov registry record · NA
Virtual Reality for Outpatient Cancer Pain Management
A NA study, sponsored by Medstar Health Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT05442866 is a NA study that has completed, run by Medstar Health Research Institute. The registered enrollment target is 33 participants.
The verdict
NCT05442866, a NA study, has completed, sponsored by Medstar Health Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
This is a non-randomized, unblinded dose-titration study to evaluate different "doses" of virtual reality to impact moderate-to-severe pain in patients living with cancer. After consenting to participate, in addition to usual pharmacologic pain management, participants will receive 1 week of VR daily for 10 minutes per session, then 1 week of VR twice a day for 10 minutes per session, then 1 week of VR use as desired by the participants.
Interventions
- DEVICE Virtual reality experience for 10 minutes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05442866
The ClinicalTrials.gov registry entry for NCT05442866 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medstar Health Research Institute, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Virtual reality experience for 10 minutes is the first listed.
NCT05442866 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05442866 about?
NCT05442866 is a clinical study titled "Virtual Reality for Outpatient Cancer Pain Management". This is a non-randomized, unblinded dose-titration study to evaluate different "doses" of virtual reality to impact moderate-to-severe pain in patients living with cancer. After consenting to participate, in addition to usual pharmacologic pain management, participants will receive 1 week of VR dail...
What is the current status of trial NCT05442866?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2022-07-01. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05442866?
The interventions under investigation include: Virtual reality experience for 10 minutes (DEVICE).
Who is sponsoring clinical trial NCT05442866?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.